11/5/2026

speaker
Conference Call Operator
Operator

Good day and welcome to the Tandem Diabetes Care third quarter 2026 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question, you will need to press star 11 on your touchstone telephone. Please note this call may be recorded. I would like to turn the call over to Susan Morrison, Executive Vice President and Chief Administrative Officer. Please go ahead.

speaker
Susan Morrison
Executive Vice President and Chief Administrative Officer

Hello and welcome to Tandem's 2026 Third Quarter Earnings Call. Today's discussion will include forward-looking statements, including statements about our CEO transition and its timing, our leadership, strategy, product pipeline, development timelines, financial performance, including profitability, and operating plans, and speak only as of today's date. These statements reflect our current expectations about future events and are subject to risk and uncertainties that could cause actual results to differ materially from those anticipated or projected in our forward-looking statements, which are described in our press release issued earlier today and under the risk factors portion of our most recent annual report on Form 10-K and quarterly report on Form 10-Q, as well as the Form 8-K we issued today. Today's discussion will also include references to both GAAP and non-GAAP financial measures. Please refer to our earnings release issued today and available on the Investor Center portion of our website for a reconciliation of non-GAAP measures to their most directly comparable GAAP financial measure and other information regarding our use of non-GAAP financial measures. In addition, we also issued a press release this afternoon on the planned evolution of Tandem CEO leadership. To speak to this announcement, the Chair of Tandem's Board of Directors, Becky Robertson, will join us in opening today's call. We'll then move to our third quarter earning results and company update from John Sheridan, President and CEO, and Leigh Vosseller, Executive Vice President and Chief Financial Officer. After their prepared remarks, we'll open the call for questions with John and Leigh. Thank you in advance for limiting yourself to one question before rejoining the queue. I'll now turn the call over to Becky.

speaker
Becky Robertson
Chair of the Board of Directors

Thanks, Susan, and good afternoon, everyone. Today's succession announcement marks an important milestone for Tandem Diabetes Care. As part of a planned leadership transition, we celebrate John Sheridan's accomplished tenure as he prepares to retire at the end of 2026. And we are thrilled to welcome Jeanette Bankas as Tandem's next president and CEO. On behalf of the board, I want to thank John for more than a decade of service to Tandem, including eight years as CEO. Under John's leadership, Tandem has grown into a global innovator in diabetes care. He launched Control IQ, our first hybrid closed-loop technology, advanced our digital health strategy, and expanded our portfolio with the introduction of Mobi. In addition, he established the foundation for Tandem to operate at scale internationally and set in motion business model changes that broaden customer access. Just as important, he cultivated a mission-driven culture that will continue to define this company. With this foundation in place, Jeanette is the right leader to guide Tandem through its next phase of growth. Jeanette stood out during the board succession planning and search process bringing more than 30 years of global operating experience and an impressive record of translating strategy into consistent execution and growth. Her experience scaling medical technology businesses is well suited for Tandem at this stage as we capitalize on a new business model and expand internationally. Jeanette's customer-centric approach, broad perspective, and commitment to innovation align closely with Tandem's culture, Mission and Priorities as we advance our technology roadmap, expand customer access, and pursue sustainable growth and profitability. She is also well-positioned to shape Tandem's long-term strategy and strengthen our competitive position. Throughout the transition, our leadership team remains focused on Tandem's strategic priorities, and the board is confident in the organization's ability to deliver. John, thank you again for your leadership and your commitment to Tandem. Jeanette, we are excited to welcome you to the company on November 16th. With that, I'll turn the call over to John.

Want transcripts like this in your own app? Try the Earnings call API, or read the transcript API docs.

Disclaimer

This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

-

-

Use this data in your own app

Pull this call's transcript, audio and slides with the Earnings call transcripts API.

See pricing

9,000+ companies · REST API